ArticleAnnals of translational medicine2020

A therapeutic perspective for proliferative vitreoretinopathy based on the inhibition of epithelial-mesenchymal transition by miR-194.

Maria Bencivenga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.